2025 annual financial data
Polaryx Therapeutics 2025 Net income growth
Direct answer
Net income growth was 70.4%.
Operating income was -7,821,000 USD and net income was -8,985,000 USD.
Operating cash flow was -3,944,000 USD.
Get free Polaryx Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,821,000 USD
- Net income
- -8,985,000 USD
- Operating cash flow
- -3,944,000 USD